Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code QSE: AlzheimerS Disease Pathology Assessment Test. Open this device type's page
3 decisions
product code QSE. Showing 1 to 3, newest first. PMA results are original approvals and panel-track supplements.
K231348 · Decided Jun 5, 2023 · 27 days after receipt
Device type: AlzheimerS Disease Pathology Assessment Test (QSE) · Laboratory Medicine & Pathology
- Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSFBreakthrough510(k)
K221842 · Decided Dec 7, 2022 · 166 days after receipt
Device type: AlzheimerS Disease Pathology Assessment Test (QSE) · Laboratory Medicine & Pathology
- Lumipulse G ß-Amyloid Ratio (1-42/1-40)New device typeBreakthroughDe Novo
DEN200072 · Decided May 4, 2022 · 530 days after receipt
Device type: AlzheimerS Disease Pathology Assessment Test (QSE) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.